Xeris Biopharma Holdings Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Cap	1,038	1,305	507	325	181	366
Market Cap Growth	16.06%	157.58%	56.05%	79.10%	-50.46%	24.75%
Enterprise Value	1,159	1,446	685.21	477.85	255.75	351.51
Last Close Price	6.02	7.85	3.39	2.35	1.33	2.93
PE Ratio	1880.26	2447.71	-9.16	-5.22	-1.90	-1.89
Forward PE	57.98	64.50	-	-	-	-
PS Ratio	3.47	4.47	2.49	1.98	1.64	7.38
PB Ratio	71.28	95.32	-17.11	-47.86	4.01	3.84
P/TBV Ratio	73.62	99.06	-16.80	-47.70	3.99	2.43
P/FCF Ratio	36.24	46.72	-13.38	-6.59	-1.75	-3.79
P/OCF Ratio	35.36	45.58	-13.70	-6.90	-1.76	-3.83
EV/Sales Ratio	3.97	4.95	3.37	2.92	2.32	7.09
EV/EBITDA Ratio	31.29	39.02	-31.76	-15.08	-3.67	-3.10
EV/EBIT Ratio	46.56	58.07	-20.37	-10.86	-3.12	-3.05
EV/FCF Ratio	41.50	51.76	-18.10	-9.70	-2.47	-3.64
Debt / Equity Ratio	18.40	18.40	-8.45	-33.28	4.35	0.92
Debt / EBITDA Ratio	6.97	6.97	-12.58	-7.23	-2.84	-0.78
Debt / FCF Ratio	9.24	9.24	-7.17	-4.65	-1.91	-0.91
Net Debt / Equity Ratio	10.74	10.74	-6.75	-23.11	1.68	-0.15
Net Debt / EBITDA Ratio	3.97	3.97	-9.26	-4.95	-1.09	0.13
Net Debt / FCF Ratio	5.27	5.27	-5.28	-3.18	-0.74	0.15
Asset Turnover	0.83	0.83	0.63	0.49	0.34	0.21
Inventory Turnover	0.73	0.73	0.85	0.90	1.06	1.01
Quick Ratio	1.48	1.48	1.12	1.17	2.08	1.52
Current Ratio	2.19	2.19	1.67	1.64	2.54	1.80
Return on Equity (ROE)	-6.96%	-6.96%	301.32%	-324.20%	-134.83%	-190.28%
Return on Assets (ROA)	7.05%	7.05%	-10.01%	-12.93%	-24.88%	-49.69%
Return on Invested Capital (ROIC)	14.34%	14.34%	-17.21%	-24.28%	-58.07%	-188.24%
Return on Capital Employed (ROCE)	10.03%	10.03%	-14.95%	-17.66%	-33.03%	-64.65%
Earnings Yield	0.05%	0.04%	-10.91%	-19.15%	-52.63%	-52.90%
FCF Yield	2.76%	2.14%	-7.47%	-15.18%	-57.06%	-26.41%
Buyback Yield / Dilution	-17.69%	-17.69%	-6.61%	-1.51%	-71.62%	-85.32%
Total Shareholder Return	-17.69%	-17.69%	-6.61%	-1.51%	-71.62%	-85.32%

Updated Mar 2, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q